Search

everythinglearnresearchcommunity

for

Search:↓

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

High-dose finasteride effectively treats hair loss in postmenopausal women.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

A postmenopausal woman with hair loss and hirsutism improved after surgery to remove an ovarian tumor.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

A rare ovarian tumor caused hair loss in a post-menopausal woman, which almost completely stopped after surgery.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.